Connect Biopharma terminates ADR program; ordinary shares to list directly on Nasdaq under CNTB

Connect Biopharma Holdings Ltd

On July 18, 2025, ordered termination of Deposit Agreement with Deutsche Bank Trust Company Americas.
ADR program and Deposit Agreement expected to terminate on or about September 2, 2025.
Each ADS (1 ordinary share) will be mandatorily cancelled and exchanged for ordinary shares 1:1.
Company plans to list ordinary shares directly on Nasdaq under symbol CNTB after ADR termination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.